Clin2
NCT07477990Possibly a fitRecruiting

Testing a digital device for anxiety treatment

General Anxiety Disorder

Part of Mental health clinical trials.

This trial is testing a digital device called Aurora that helps treat moderate to severe anxiety. It compares the device to standard anxiety medications, so you may receive either the device or a pill. The goal is to see if the device can work as well as medication without the side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
162 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with generalized anxiety disorder by a doctor.
  • Your score on the GAD-7 anxiety questionnaire is 10 or higher.
  • You do not have a problem with alcohol or recreational drugs.
  • You have not taken any psychiatric medication in the last 6 months.
  • You are willing to use a digital device (like a smartphone or tablet) to help with your anxiety.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07759128Recruiting· Phase 3
Test of a new anxiety medication for adults with generalized anxiety disorder

This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.

Jacksonville, Florida
NCT07767903Recruiting· Phase 3
Study of a new medicine for generalized anxiety disorder

This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.

Cherry Hill, New Jersey
NCT04663724Recruiting
Computer-based treatment for social anxiety disorder

This study is testing a computer-based treatment for social anxiety disorder. It may help reduce anxiety in social situations through a structured online program, and it also includes brain imaging (MRI) to see how the treatment affects the brain.

New York, New York
NCT07786454Not yet recruiting· Phase 3
Extended treatment for generalized anxiety disorder

This trial tests whether an already-studied medication, SEP-363856, can continue to safely help adults with generalized anxiety disorder over a longer period. It may offer ongoing symptom relief for people who completed a previous study of this drug.

NCT07299916Enrolling by invitation
Brain stimulation and virtual reality for anxiety disorders

This trial tests if a combination of non-invasive brain stimulation (tDCS) and virtual reality meditation can reduce anxiety in people with Generalized Anxiety Disorder or related conditions. It aims to find a new, non-medication way to help manage symptoms.

Hong Kong
NCT07140497Not yet recruiting
Reducing anxiety in people with hearing or mobility issues

This trial tests a program that combines digital cognitive behavioral therapy (a type of talk therapy using an app or computer) with health coaching to help reduce anxiety in people who have hearing or mobility disabilities.

Dover, Delaware

Hear when a new General Anxiety Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.